GI Innovation, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2017-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.gi-innovation.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Phase 1
Recruiting
- Conditions
- Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)Platinum-resistant Ovarian Cancer (PROC)Hepatocellular Carcinoma (HCC)Colorectal Cancer (CRC)HER2 Negative Breast CancerCutaneous MelanomaRenal Cell Carcinoma (RCC)
- Interventions
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- GI Innovation, Inc.
- Target Recruit Count
- 358
- Registration Number
- NCT05824975
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Minnesota, Rochester, Minnesota, United States
GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Cervical CancerVaginal CancerRenal Cell CarcinomaMelanomaSarcomaMicrosatellite Stable Colorectal CarcinomaEsophageal Squamous Cell CarcinomaVulvar CancerAdvanced Solid TumorNon-small Cell Lung Cancer
- Interventions
- Radiation: Local Radiotherapy
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- GI Innovation, Inc.
- Target Recruit Count
- 430
- Registration Number
- NCT04977453
- Locations
- 🇺🇸
Tisch Cancer Institute (TCI), Icahn School of Medicine, New York, New York, United States
🇺🇸Carolina Biooncology Institute, Huntersville, North Carolina, United States
🇰🇷The Catholic University of Korea St. Vincent's Hospital, Suwon-si, Kyeonggi-do, Korea, Republic of
News
No news found